We are live on ! Find out more
TRAW icon

Traws Pharma
TRAW

9 hedge funds and large institutions have $1.51M invested in Traws Pharma in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more funds holding

Funds holding: 8 → 9 (+1)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

39% less capital invested

Capital invested by funds: $2.5M → $1.51M (-$983K)

Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
–
Calls
$3K
Puts
–
Net Calls
+$3K
Net Calls Change
+$37K

Top Buyers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
+$107K
2
VKH
Virtu KCG Holdings
New York
+$107K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$107K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$400K – – –
WMSA
2
Weiss Multi-Strategy Advisers
New York
$328K – – –
Citigroup
3
Citigroup
New York
$201K +$107K +1 +50%
Renaissance Technologies
4
Renaissance Technologies
New York
$94K -$107K -1 -50%
Jacobs Levy Equity Management
5
Jacobs Levy Equity Management
New Jersey
$92K – – –
Royal Bank of Canada
6
Royal Bank of Canada
Ontario, Canada
$67K – – –
Geode Capital Management
7
Geode Capital Management
Massachusetts
$62K – – –
VKH
8
Virtu KCG Holdings
New York
$59K +$107K +1 New
BFA
9
BlackRock Fund Advisors
California
$46K – – –
HK
10
Horizon Kinetics
New York
$33K – – –
Goldman Sachs
11
Goldman Sachs
New York
$32K – – –
HighTower Advisors
12
HighTower Advisors
Illinois
$25K – – –
Northern Trust
13
Northern Trust
Illinois
$25K – – –
BCM
14
Bridgeway Capital Management
Texas
$16K – – –
UBS Group
15
UBS Group
Switzerland
$15K – – –
Bank of America
16
Bank of America
North Carolina
$10K – – –
BIM
17
BlackRock Investment Management
Delaware
$3K – – –
Morgan Stanley
18
Morgan Stanley
New York
$3K – – –
DA
19
Dunvegan Associates
California
$1K – – –
Manulife (Manufacturers Life Insurance)
20
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1 – – –

TRAW Hedge Fund Activity: Q3 2015 in Review

9 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Traws Pharma (TRAW) for Q3 2015, worth a combined $1.51M — down 39% from $2.5M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new TRAW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Citigroup, adding an estimated $107K. The largest seller was Renaissance Technologies, cutting an estimated $107K.

  • 9 institutional investors held Traws Pharma (TRAW) as of Q3 2015, up from 8 in Q2 2015.
  • Funds reported $1.51M of Traws Pharma stock for Q3 2015, down 39% quarter-over-quarter.
  • 1 fund opened new Traws Pharma positions in Q3 2015 and 0 closed out, a net change of +1 holder.
  • The largest Traws Pharma buyer in Q3 2015 was Citigroup, an estimated $107K added.
  • The largest Traws Pharma seller in Q3 2015 was Renaissance Technologies, an estimated $107K sold.

Based on aggregated 13F filings for Q3 2015.